Frailty and heart disease

International Journal of Cardiology

Volumn 168, Issue 3, 2013, Pages 1745-1747

  Von Haehling, Stephan ^a   Anker, Stefan D ^a,b   Doehner, Wolfram ^a   Morley, John E ^c   Vellas, Bruno ^d,e  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b IRCCS san Rafaette   (Italy)

^c SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Faculté de Médecine Centre Hospitalo universitaire   (France)

^e TOULOUSE UNIVERSITY HOSPITAL   (France)

Author keywords

Aging; Frailty; Geriatrics; Heart disease

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PERINDOPRIL; TESTOSTERONE;

AGED; COMORBIDITY; DEATH; DISEASE ASSOCIATION; EXERCISE; FRAIL ELDERLY; HEART DISEASE; HEART INFARCTION; HOSPITALIZATION; HUMAN; PHYSICAL PERFORMANCE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; QUESTIONNAIRE; REVIEW;

AGING; FRAILTY; GERIATRICS; HEART DISEASE;

AGED, 80 AND OVER; DISEASE MANAGEMENT; FRAIL ELDERLY; HEART DISEASES; HUMANS; MASS SCREENING;

EID: 84885657267     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.07.068     Document Type: Editorial

References (85)

1. J.E. Morley Developing novel therapeutic approaches to frailty Curr Pharm Des 15 2009 3384 3395
2. M.E. Rougé Bugat, P. Cestac, S. Oustric, B. Vellas, and F. Nourhashemi Detecting frailty in primary care: a major challenge for primary care physicians J Am Med Dir Assoc 13 2012 669 672
3. J.E. Morley, H.M. Perry III, and D.K. Miller Editorial: something about frailty J Gerontol A Biol Sci Med Sci 57 2002 M698 M704
4. K.P. Alexander, L.K. Newby, and C.P. Cannon American Heart Association Council on Clinical Cardiology; Society of Geriatric Cardiology. Acute coronary care in the elderly. Part I: non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the AHA Council on Clinical cardiology: in collaboration with the Society of Geriatric Cardiology Circulation 15 2007 2549 2569
5. J.E. Morley, B. Vellas, and G. Abellan van Kan Frailty consensus: a call to action J Am Med Dir Assoc 14 2013 392 397
6. L.P. Fried, C.M. Tangen, and J. Walston Frailty in older adults: evidence for a phenotype J Gerontol A Biol Sci Med Sci 56 2001 M146 M156
7. G. Abellan van Kan, Y. Rolland, H. Bergman, J.E. Morley, S.B. Kritchevsky, and B. Vellas The I.A.N.A. Task Force on frailty assessment of older people in clinical practice J Nutr Health Aging 12 2008 29 37
8. J.E. Morley, T.K. Malmstrom, and D.K. Miller A simple frailty questionnaire (FRAIL) predicts outcomes in middle aged African Americans J Nutr Health Aging 16 2012 601 608
9. J. Woo, J. Leung, and J.E. Morley Comparison of frailty indicators based on clinical phenotype and the multiple deficit approach in predicting mortality and physical limitation J Am Geriatr Soc 60 2012 1478 1486
10. Z. Hyde, L. Flicker, and O.P. Almeida Low free testosterone predicts frailty in elderly men: the health in men study J Clin Endocrinol Metab 95 2010 3165 3172
11. D. Lopez, L. Flicker, and A. Dobson Validation of the frail scale in a cohort of older Australian women J Am Geriatr Soc 60 2012 171 173
12. E.O. Hoogendijk, and H.P. van Hout Investigating measurement properties of the Groningen Frailty indicator: a more systematic approach is needed J Am Med Dir Assoc 13 2012 757 [author reply 757-758]
13. K.E. Ensrud, S.K. Ewing, and B.C. Taylor Comparison of 2 frailty indexes for prediction of falls, disability, fractures, and death in older women Arch Intern Med 168 2008 382 389
14. K. Rockwood, M.J. Abeysundera, and A. Mitnitski How should we grade frailty in nursing home patients? J Am Med Dir Assoc 8 2007 595 603
15. A. Chin, J.M. Dekker, E.J. Feskens, E.G. Schouten, and D. Kromhout How to select a frail elderly population? A comparison of three working definitions J Clin Epidemiol 52 1999 1015 1021
16. A.B. Newman, J.S. Gottdiener, and M.A. McBurnie Associations of subclinical cardiovascular disease with frailty J Gerontol A Biol Sci Med Sci 56 2001 M158 M166
17. B.E. Klein, R. Klein, M.D. Knudtson, and K.E. Lee Frailty, morbidity and survival Arch Gerontol Geriatr 41 2005 141 149
18. N.F. Woods, A.Z. LaCroix, and S.L. Gray Women's Health Initiative. Frailty: emergence and consequences in women aged 65 and older in the Women's Health Initiative Observational Study J Am Geriatr Soc 53 2005 1321 1330
19. P.H. Chaves, R.D. Semba, and S.X. Leng Impact of anemia and cardiovascular disease on frailty status of community-dwelling older women: the Women's Health and Aging Studies I and II J Gerontol A Biol Sci Med Sci 60 2005 729 735
20. F. Cacciatore, P. Abete, and F. Mazzella Frailty predicts long-term mortality in elderly subjects with chronic heart failure Eur J Clin Invest 35 2005 723 730
21. J.L. Purser, M.N. Kuchibhatla, G.G. Fillenbaum, T. Harding, E.D. Peterson, and K.P. Alexander Identifying frailty in hospitalized older adults with significant coronary artery disease J Am Geriatr Soc 54 2006 1674 1681
22. A.B. Newman, E.M. Simonsick, and B.L. Naydeck Association of long-distance corridor walk performance with mortality, cardiovascular disease, mobility limitation, and disability JAMA 295 2006 2018 2026
23. R.S. Boxer, Z. Wang, S.J. Walsh, D. Hager, and A.M. Kenny The utility of the 6-minute walk test as a measure of frailty in older adults with heart failure Am J Geriatr Cardiol 17 2008 7 12
24. R. Boxer, A. Kleppinger, A. Ahmad, K. Annis, D. Hager, and A. Kenny The 6-minute walk is associated with frailty and predicts mortality in older adults with heart failure Congest Heart Fail 16 2010 208 213
25. E. Sánchez, M.T. Vidán, J.A. Serra, F. Fernández- Avilés, and H. Bueno Prevalence of geriatric syndromes and impact on clinical and functional outcomes in older patients with acute cardiac diseases Heart 97 2011 1602 1606
26. G. Pulignano, D. Del Sindaco, and A. Ki Lenarda Usefulness of frailty profile for targeting older heart failure patients in disease management programs: a cost-effectiveness, pilot study J Cardiovasc Med (Hagerstown) 11 2010 739 747
27. J. Lupón, B. González, and S. Santaeugenia Prognostic implicator of frailty and depressive symptoms in an outpatient population with heart failure Rev Esp Cardiol 61 2008 835 842
28. J. Afilalo, S. Karunananthan, M.J. Eisenberg, K.P. Alexander, and H. Bergman Role of frailty in patients with cardiovascular disease Am J Cardiol 103 2009 1616 1621
29. J.E. Morley Frailty: diagnosis and management J Nutr Health Aging 15 2011 667 670
30. L.P. Fried, R.A. Kronmal, and A.B. Newman Risk factors for 5-year mortality in older adults: the Cardiovascular Health Study JAMA 279 1998 585 592
31. S. Bossoni, G. Mazziotti, and C. Gazzaruso A relationship between instrumental activities of daily living and blood glucose control in elderly subjects with type 2 diabetes Age Ageing 37 2008 222 225
32. S.D. Anker, and A.J. Coats Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation Chest 115 1999 836 847
33. S.X. Leng, Q.L. Xue, Y. Huang, L. Ferrucci, L.P. Fried, and J.D. Walston Baseline total and specific differential white blood cell counts and 5-year all-cause mortality in community-dwelling older women Exp Gerontol 40 2005 982 987
34. M.T. Haren, T.K. Malmstrom, and D.K. Miller Higher C-reactive protein and soluble tumor necrosis factor receptor levels are associated with poor physical function and disability: a cross-sectional analysis of a cohort of late middle-aged African Americans J Gerontol A Biol Sci Med Sci 65 2010 274 281
35. N.M. Di, and F. Papa Inflammation, hemostatic markers, and antithrombotic agents in relation to long-term risk of new cardiovascular events in first-ever ischemic stroke patients Stroke 33 2002 1763 1771
36. I. Tzoulaki, G.D. Murray, A.J. Lee, A. Rumley, G.D. Lowe, and F.G. Fowkes Relative value of inflammatory, hemostatic, and rheological factors for incident myocardial infarction and stroke: the Edinburgh artery study Circulation 115 2007 2119 2127
37. E.A. Jankowska, G. Filippatos, and B. Ponikowska Reduction in circulating testosterone relates to exercise capacity in men with chronic heart failure J Card Fail 15 2009 442 450
38. A. Tajar, D.M. Lee, and S.R. Pye The association of frailty with serum 25-hydroxyvitamin D and parathyroid hormone levels in older European men Age Ageing 42 2013 352 359
39. E.F. Binder, K.B. Schechtman, and A.A. Ehsani Effects of exercise training on frailty in community-dwelling older adults: results of a randomized, controlled trial J Am Geriatr Soc 50 2002 1921 1928
40. O. Theou, L. Stathokostas, and K.P. Roland The effectiveness of exercise interventions for the management of frailty: a systematic review J Aging Res 2011 Apr 4 2011 569194
41. T. Valenzuela Efficacy of progressive resistance training interventions in older adults in nursing homes: a systematic review J Am Med Dir Assoc 13 2012 418 428
42. E.J. Davies, T. Moxham, and K. Rees Exercise based rehabilitation for heart failure Cochrane Database Syst Rev 4 April 14 2010 CD003331
43. B.S. Heran, J.M. Chen, and S. Ebrahim Exercise-based cardiac rehabilitation for coronary heart disease Cochrane Database Syst Rev 7 Jul 6 2011 CD001800
44. A.J. Coats Research on cachexia, sarcopenia and skeletal muscle in cardiology J Cachexia Sarcopenia Muscle 3 2012 219 223
45. S. Von Haehling, J.E. Morley, and S. Anker From muscle wasting to sarcopenia and myopenia: update 2012 J Cachexia Sarcopenia Muscle 3 2012 213 217
46. S. Fulster, M. Tacke, and A. Sandek Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF) Eur Heart J 34 2013 512 519
47. N.A. Singh, S. Quine, and L.M. Clemson Effects of high-intensity progressive resistance training and targeted multidisciplinary treatment of frailty on mortality and nursing home admissions after hip fracture: a randomized controlled trial J Am Med Dir Assoc 13 2012 24 30
48. K. Lenk, G. Schuler, and V. Adams Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training J Cachexia Sarcopenia Muscle 1 2010 9 21
49. M. Zamboni, A. Rossi, F. Corzato, C. Bambace, G. Mazzali, and F. Fantin Sarcopenia, cachexia and congestive heart failure in the elderly Endocr Metab Immune Disord Drug Targets 13 2013 58 67
50. S. von Haehling, J.E. Morley, and S.D. Anker J Cachexia Sarcopenia Muscle 1 2010 129 133
51. J.E. Morley, A.M. Abbatecola, and J.M. Argiles Sarcopenia with limited mobility: an international consensus J Am Med Dir Assoc 12 2011 403 409
52. D. Scott, L. Blizzard, J. Fell, and G. Jones The epidemiology of sarcopenia in community living older adults: what role does lifestyle play? J Cachexia Sarcopenia Muscle 2 2011 125 134
53. K.K. Witte, and A.L. Clark Why does chronic heart failure cause breathlessness and fatigue? Prog Cardiovasc Dis 49 2007 366 384
54. B. Mettauer, J. Zoll, A. Garnier, and R. Ventura-Clapier Heart failure: a model of cardiac and skeletal muscle energetic failure Pflugers Arch 452 2006 653 666
55. S.D. Anker, J.W. Swan, and M. Volterrani The influence of muscle mass, strength, fatigability and blood flow on exercise capacity in cachectic and non-cachectic patients with chronic heart failure Eur Heart J 18 1997 259 269
56. M. Tieland, M.L. Dirks, and N. van der Zwaluw Protein supplementation increases muscle mass gain during prolonged resistance-type exercise training in frail elderly people: a randomized, double-blind, placebo-controlled trial J Am Med Dir Assoc 13 2012 713 719
57. M. Tieland, O. van de Rest, and M.L. Dirks Protein supplementation improves physical performance in frail elderly people: a randomized, double-blind, placebo-controlled trial J Am Med Dir Assoc 13 2012 720 726
58. F. Neelemaat, J.E. Bosmans, A. Thijs, J.C. Seidel, and M.A. van Bokhorst-de van der Schureren Post-discharge nutritional support in malnourished elderly individuals improves functional limitations J Am Med Dir Assoc 12 2011 295 301
59. R.S. Boxer, D.A. Dauser, S.J. Walsh, W.D. hager, and A.M. Kenny The association between vitamin D and inflammation with the 6-minute walk and frailty in patients with heart failure J Am Geriatr Soc 56 2008 454 461
60. A. Mithal, J.P. Bomjour, and S. Boonen Impact of nutrition on muscle mass, strength, and performance in older adults Osteoporos Int 24 2013 1555 1566
61. D. Sumukadas, M.D. Witham, A.D. Struthers, and M.E. McMurdo Effect of perindopril on physical function in elderly people with functional impairment: a randomized controlled trail CMAJ 177 2007 867 874
62. J.E. Morley Anabolic steroids and frailty J Am Med Dir Assoc 11 2010 533 536
63. T.G. Travison, S. Basaria, and T.W. Storer Clinical meaningfulness of the changes in muscle performance and physical function associated with testosterone administration in older men with mobility limitation J Gerontol A Biol Sci Med Sci 66 2011 1090 1099
64. U. Srinivas-Shankar, S.A. Roberts, and M.J. Connolly Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study J Clin Endocrinol Metab 95 2010 639 650
65. F. Iellamo, M. Volterrani, and G. Caminiti Testosterone therapy in women with chronic heart failure: a pilot double-blind, randomized, placebo-controlled study J Am Coll Cardiol 56 2010 1310 1316
66. M. Stout, G.A. Tew, and H. Doll Testosterone therapy during exercise rehabilitation in male patients with chronic heart failure who have low testosterone status: a double-blind randomized controlled feasibility study Am Heart J 164 2012 893 901
67. G. Caminiti, M. Volterrani, and F. Iellamo Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure: a double-blind placebo-controlled, randomized study J Am Coll Cardiol 54 10 2009 919 927
68. M. Thakur, and D.G. Blazer Depression in long-term care J Am Med Dir Assoc 9 2008 82 87
69. J. Comin-Colet, M. Lainscak, and K. Dickstein The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study Eur Heart J 34 2013 30 38
70. P. Attanasio, C. Ronco, S.D. Anker, M. Cicoira, and S. von Haehling Role of iron deficiency and anemia in cardio-renal syndromes Semin Nephrol 32 2012 57 62
71. S.D. Anker, J. Comin Colet, and G. Filippatos Ferris carboxymaltose in patients with heart failure and iron deficiency N Engl J Med 361 2009 2436 2448
72. S.P. Fitzgerald, and N.G. Bean An analysis of the interactions between individual comorbidities and their treatments - implications for guidelines and polypharmacy J Am Med Dir Assoc 11 2010 475 484
73. M.O. Little, and A. Morley Reducing polypharmacy: evidence from a simple quality improvement initiative J Am Med Dir Assoc 14 2013 152 156
74. B.A. Golomb, M.A. Evans, J.E. Dimsdale, and H.L. White Effects of statins on energy and fatigue with exertion: results from a randomized controlled trial Arch Intern Med 172 2012 1180 1182
75. A.C. Perez, P. Jhund, D. Preiss, J. Kjekshus, and J.J.V. McMurray Effect of Rosuvastatin on fatigue in patients with heart failure J Am Coll Cardiol 61 2013 1121 1122
76. G.M. Krishnan, and P.D. Thompson The effects of statins on skeletal muscle strength and exercise performance Curr Opin Lipidol 21 2010 324 328
77. K.P. Padala, P.R. Padala, D.P. McNeilly, J.A. Geske, D.H. Sullivan, and J.F. Potter The effect of HMG-CoA reductase inhibitors on cognition in patients with Alzheimer's dementia: a prospective withdrawal and rechallenge pilot study Am J Geriatr Pharmacother 10 2012 296 302
78. J.E. Morley Hypertension: is it overtreated in the elderly? J Am Med Dir Assoc 11 2010 147 152
79. G. Kojima, C. Bell, and B. Tamura Reducing cost by reducing polypharmacy: the polypharmacy outcomes project J Am Med Dir Assoc 13 2012 818.e11-5
80. J.H. Flaherty, H.M. Perry III, G.S. Lynchard, and J.E. Morley J Gerontol A Biol Sci Med Sci 55 10 2000 M554 M559
81. J.E. Morley Undernutrition: a major problem in nursing homes J Am Med Dir Assoc 12 2011 243 246
82. S.J. Pocock, J.J. McMurray, and J. Dobson Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme Eur Heart J 29 2008 2641 2650
83. M. Lainscak, M. Podbregar, and S.D. Anker How does cachexia influence survival in cancer, heart failure and other chronic diseases? Curr Opin Support Palliat Care 1 2007 299 305
84. Y. Rolland, A. Perrin, V. Gardette, N. Filhol, and B. Vellas Screening older people at risk of malnutrition or malnourished using the Simplified Nutritional Appetite Questionnaire (SNAQ): a comparison with the Mini-Nutritional Assessment (MNA) tool J Am Med Dir Assoc 13 2012 31 34
85. J.E. Morley Weight loss in older persons: new therapeutic approaches Curr Pharm Des 13 2007 3637 3647